Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004085

Chief Executive Officer gave up 5,569 shares (to pay taxes)

  • Chief Executive Officer acquired 542,092 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gibson Christopher Chief Executive Officer 2025-02-03 Grant or award +525,283 1,261,916 D: show line 1 in the form
Gibson Christopher Chief Executive Officer 2025-02-03 Grant or award +16,809 1,278,725 D: show line 2 in the form
Gibson Christopher Chief Executive Officer 2025-02-03 Shares withheld for taxes −5,569 $7.25 $40,375 1,273,156 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gibson Christopher Chief Executive Officer 2025-02-03 Grant or award · Stock Option (Right to Buy) +1,050,567 1,050,567 D: show line 4 in the form
Loading xslF345X05/wk-form4_1738792209.xml…